Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CarGurus A | CARG | Mar 14, 2025 | 30.78 | +2.12 |
Caribou Biosciences | CRBU | Mar 14, 2025 | 1.01 | +2.49 |
Carisma Therapeutics | CARM | Mar 14, 2025 | 0.41 | +2.32 |
Carlisle Companies | CSL | Mar 14, 2025 | 335.91 | +2.90 |
Carlyle Credit Income Fund | CCIF | Mar 14, 2025 | 7.78 | +1.33 |
Carlyle Credit Income Fund | CCIA | Mar 14, 2025 | 25.87 | +0.04 |
Carlyle Secured Lending | CGBD | Mar 14, 2025 | 16.75 | +1.70 |
CarMax | KMX | Mar 14, 2025 | 69.90 | +0.94 |
Carmell | CTCX | Mar 14, 2025 | 0.20 | 0.00 |
Carnival | CCL | Mar 14, 2025 | 19.92 | +4.18 |
Carnival ADR | CUK | Mar 14, 2025 | 18.02 | +3.68 |
CarParts.com | PRTS | Mar 14, 2025 | 1.03 | +4.79 |
Carpenter Technology | CRS | Mar 14, 2025 | 183.50 | +4.03 |
Carriage Services | CSV | Mar 14, 2025 | 37.64 | +1.32 |
Carrier Global | CARR | Mar 14, 2025 | 66.53 | +3.55 |
Cars.com | CARS | Mar 14, 2025 | 11.39 | +2.24 |
Carter Bankshares | CARE | Mar 14, 2025 | 16.56 | +2.48 |
Carters | CRI | Mar 14, 2025 | 39.79 | -0.23 |
Cartesian Growth II A | RENE | Mar 14, 2025 | 11.81 | 0.00 |
Cartesian Growth II Unit | RENEU | Mar 14, 2025 | 11.69 | 0.00 |
Cartesian Therapeutics | RNAC | Mar 14, 2025 | 15.80 | -4.88 |
Carvana | CVNA | Mar 14, 2025 | 181.18 | +8.71 |
Carver Bancorp | CARV | Mar 14, 2025 | 1.38 | -6.76 |
Casella Waste Systems A | CWST | Mar 14, 2025 | 107.50 | +1.16 |
Caseys General Stores | CASY | Mar 14, 2025 | 395.63 | +2.76 |
CASI Pharmaceuticals | CASI | Mar 14, 2025 | 2.23 | +7.49 |
Cass Information Systems | CASS | Mar 14, 2025 | 43.16 | +1.12 |
Cassava Sciences | SAVA | Mar 14, 2025 | 2.79 | +6.90 |
Castellum | CTM | Mar 14, 2025 | 1.18 | +6.31 |
Castle Biosciences | CSTL | Mar 14, 2025 | 19.29 | +2.83 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.